apomorphine has been researched along with Dermatitis Medicamentosa in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgemeester, RWK; Schuttelaar, MLA; van Laar, T | 1 |
| Annic, A; Defebvre, L; Destée, A; Devos, D; Dujardin, K; Kreisler, A; Moreau, C; Mutez, E; Rambour, M; Salleron, J; Simonin, C | 1 |
| Edwards, H; James, CA; Lees, A; Poltawski, L; Todd, A; Watson, T | 1 |
| James, CA; Todd, A | 1 |
| Astorga, S; Espinosa, R; Fernández, S; Foncubierta, A; Gutiérrez, D; Leon, A | 1 |
| Carballo-Cordero, M; Giménez de Béjar, V | 1 |
| Loewe, R; Petzelbauer, P; Püspök-Schwarz, M | 1 |
| Burkhard, PR; Castillo, V; Coeytaux, A; Hauser, C; Oppliger, R; Pot, C | 1 |
| Bruijn, JA; Neef, C; Pavel, S; Rutgers, AW; van Hilten, B; van Laar, T | 1 |
| Acland, KM; Churchyard, A; Dowd, PM; Fletcher, CL; Lees, A; Turner, K | 1 |
1 review(s) available for apomorphine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Apomorphine nodules in Parkinson's disease: best practice considerations.
Topics: Antiparkinson Agents; Apomorphine; Drug Eruptions; Humans; Infusions, Subcutaneous; Parkinson Disease | 2008 |
1 trial(s) available for apomorphine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study.
Topics: Aged; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Drug Eruptions; Female; Hardness; Humans; Infusions, Parenteral; Male; Middle Aged; Parkinson Disease; Pilot Projects; Sample Size; Subcutaneous Tissue; Ultrasonic Therapy | 2009 |
8 other study(ies) available for apomorphine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases.
Topics: Adult; Aged; Apomorphine; Dopamine Agonists; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Infusions, Subcutaneous; Male; Parkinson Disease; Patch Tests; Preservatives, Pharmaceutical; Sulfites | 2018 |
[Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Drug Eruptions; Drug Evaluation; Female; Hallucinations; Humans; Infusions, Subcutaneous; Male; Middle Aged; Parkinson Disease; Patient Acceptance of Health Care; Quality of Life; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Immediate type 1 hypersensitivity to apomorphine: a case report.
Topics: Antiparkinson Agents; Apomorphine; Double-Blind Method; Drug Eruptions; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Injections, Subcutaneous; Intradermal Tests; Male; Middle Aged; Patch Tests; Single-Blind Method; Skin Tests; Sulfites | 2011 |
[Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].
Topics: Adrenal Cortex Hormones; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Cholinesterase Inhibitors; Combined Modality Therapy; Disease Susceptibility; Dopamine Agonists; Drug Eruptions; Hallucinations; Humans; Infusions, Subcutaneous; Mental Disorders; Parkinson Disease; Physical Therapy Modalities; Psychomotor Agitation; Psychoses, Substance-Induced; Severity of Illness Index; Sleep Wake Disorders | 2012 |
[Apomorphine hyperpigmentation].
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Aged; Antigens, CD; Antiparkinson Agents; Apomorphine; Diagnosis, Differential; Drug Eruptions; Humans; Hyperpigmentation; Injections, Subcutaneous; Langerhans Cells; Male; Melanins; Melanocytes; Melanoma; Membrane Glycoproteins; Oxidation-Reduction; Parkinson Disease; Skin | 2003 |
Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.
Topics: Antiparkinson Agents; Apomorphine; Dopamine Agonists; Drug Eruptions; Female; Humans; Hypereosinophilic Syndrome; Middle Aged; Panniculitis; Parkinson Disease | 2005 |
The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic study.
Topics: Abdominal Muscles; Antiparkinson Agents; Apomorphine; Chelating Agents; Drug Combinations; Drug Eruptions; Edetic Acid; Female; Humans; Injections, Subcutaneous; Longitudinal Studies; Male; Middle Aged; Vasculitis, Leukocytoclastic, Cutaneous | 1998 |
Panniculitis in association with apomorphine infusion.
Topics: Antiparkinson Agents; Apomorphine; Drug Eruptions; Eosinophilia; Humans; Infusions, Parenteral; Mast Cells; Middle Aged; Panniculitis | 1998 |